Source: International Congress 2017 – Cystic fibrosis: monitoring and biomarkers
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Lammertyn (LEUVEN, Belgium). The association between leukocyte telomere length, telomere attrition and disease severity in cystic fibrosis patients. 4402

Member's Comments

No comment yet.

Related content which might interest you: Telomere length and genetic variant associations with interstitial lung disease progression and survival Source: Eur Respir J, 53 (4) 1801641; 10.1183/13993003.01641-2018 Year: 2019 Telomere length in circulating leukocytes is associated with lung function and disease Source: Eur Respir J 2014; 43: 983-992 Year: 2014 Telomere length in patients with unclassifiable interstitial lung disease: a cohort study Source: Eur Respir J, 56 (2) 2000268; 10.1183/13993003.00268-2020 Year: 2020 Association between leukocyte telomere length (LTL) and functional decline in patients with Idiopathic Pulmonary Fibrosis (IPF) on antifibrotic treatment Source: International Congress 2019 – The evolving field of idiopathic interstitial pneumonia Year: 2019 Increase in post-transplant survival and quality of life in pulmonary fibrosis with and without telomere dysfunction Source: Virtual Congress 2020 – Possible scenarios in the challenging future of rare diffuse parenchymal lung diseases Year: 2020 Low income and progression free survival in idiopathic pulmonary fibrosis: an association to  uncover Source: Virtual Congress 2020 – What is hot in idiopathic pulmonary fibrosis? Year: 2020 Telomerase and telomere length in lung fibrosis: what does it mean? Source: ERS Research Seminar 2017 – Integrating systems biology approach in idiopathic pulmonary fibrosis research Year: 2016 Telomere (TL) shortening is associated with disease severity in scleroderma (SSC) associated interstitial lung disease (ILD) Source: Annual Congress 2012 - Interstitial lung disease: from bench to bedside Year: 2012 Association between shorter telomeres’ length and Eotaxin-1 in children with severe asthma, an indicative of accelerated aging. Source: International Congress 2019 – Cellular metabolism and immune senescence in lung pathology Year: 2019 Telomere length in blood leukocytes of patients with bronchiectasis Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases Year: 2017 IL8 as a marker of severity of disease progression in patients with idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2007; 30: Suppl. 51, 373s Year: 2007 The cumulative effect of inflammation and infection on structural lung disease in early cystic fibrosis Source: Eur Respir J, 54 (1) 1801771; 10.1183/13993003.01771-2018 Year: 2019 Bacterial burden in the lower airways predicts disease progression in idiopathic pulmonary fibrosis and is independent of radiological disease extent Source: Eur Respir J, 55 (4) 1901519; 10.1183/13993003.01519-2019 Year: 2020 Telomere length, COPD and emphysema as risk factors for lung cancer Source: Eur Respir J 2017; 49(1): 1601521; DOI: 10.1183/13993003.01521-2016 Year: 2017 Post-transplant morbidity and mortality in patients with pulmonary fibrosis and telomeric shortening Source: International Congress 2017 – The wide spectrum of ILDs Year: 2017 Peripheral blood leukocyte telomere length is associated with survival of sepsis patients Source: Eur Respir J, 55 (1) 1901044; 10.1183/13993003.01044-2019 Year: 2020 Correlation of a progression of fibrotic changes in idiopathic pulmonary fibrosis 1 year after a diagnosis with initial functional and immunologic parameters Source: Eur Respir J 2004; 24: Suppl. 48, 667s Year: 2004 Telomere length in circulating leukocytes is associated with lung function and disease Source: Annual Congress 2013 –Risk factors for COPD and lung function decline Year: 2013 Longitudinal serological assessment of neutrophil activity is related to disease progression in idiopathic pulmonary fibrosis Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021 Clinical characteristics and disease severity of adults with cystic fibrosis with at least one residual function mutation Source: International Congress 2018 – Cystic fibrosis in adults: current research Year: 2018